GSK CEO wants to boost investment in R&D

GlaxoSmithKline CEO Jean-Pierre Garnier said he wants to boost investment in research and development of new drugs in order to put the company in place to become the "Microsoft of the pharmaceuticals industry," a vision first proposed by the head of Glaxo Wellcome. "We have a chance to step away from the rest of our competition if we execute our plan well and we're now in a position to do so," he said.

View Full Article in:

Independent (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA